[ Skip to main content ]

Show me the money!

stacks of hundies

Whether we’re treating drug issues in the health sector or enforcing the Misuse of Drugs Act in the law enforcement and justice sector, addressing drug-related harm isn’t cheap. The relative funding we allocate to health approaches like treating drug addiction versus law enforcement approaches like imprisonment affects our outcomes in reducing drug harm.

The weight of international preventive and drug harm reduction evidence demonstrates it’s more effective to tackle drug problems predominantly with a public health, social support and strong regulatory approach than a criminal justice approach. Criminal justice approaches can actually make the problem worse
by hampering access to treatment and increasing health and social problems for people who use drugs. However, for many years, it’s been widely acknowledged that we put significantly more funding into our criminal justice-based enforcement approach to drugs than our health and socially focused approach.

While it’s not easy to get good data on funding and costs around these endeavours, we present some of the available figures
 below.

Alcohol and other drug treatment services (2012/13 financial year)

Vote: Health

Vote: Health
Funding $116,236,789
Funding for young people under 19 years $15 million (approx.)
Number of people treated 46,641
Average cost per person treated $2,492
Full-time equivalent workforce positions funded 1,452

 Vote: Corrections

Vote: Corrections
Funding $5,415,000

Average cost per prison-based drug and alcohol treatment programme participant

$5,154
Number of prisoners who completed an alcohol and drug programme (prison-based and community) 1,507

Harm reduction (Needle Exchange Programme)

Drug harm reduction activity, designed to reduce the harm occurring from drug use for those unable or unwilling to stop, is one of the most cost-effective ways to use funding. New Zealand’s Needle Exchange Programme (NEP) is an excellent example of this.

A review of the effectiveness/efficiency of the New Zealand NEP between 1988 and 2001, also applying evidence from an Australian review of needle exchange programmes, reveals some impressive harm reduction figures.

Total net benefit of lifetime hepatitis C and HIV treatment savings from infections prevented between 1998 and 2001 was estimated at $202 million. 

Needle Exchange Programme (NEP)
NEP total current Vote: Health funding $4.75 million
(approx. per annum)
Blood-borne infections/deaths avoided between 1988 and 2001 HIV – 1,031 cases/20 deaths Hepatitis C – 1,454 cases

Enforcement costs

There is a particular lack of current, accurate and comprehensive information available on government drug enforcement costs. However, the figures below were presented in the New Zealand Police’s New Zealand Drug Harm Index published in 2008. Drugs covered by the index were cannabis, opioids (opium, homebake, heroin, morphine), stimulants (cocaine, amphetamine, methamphetamine, ecstasy) and LSD.

Illicit drug enforcement costs 2005/06 ($ million)
Prisons 110.5
Police 106.9
Criminal courts 40
Customs 24.7
Community sentences 20.9
Total  303

The figures presented support the generally accepted view that we spend considerably more on drug enforcement than on drug treatment and harm reduction. However, these figures are not comprehensive, and the accuracy, particularly of the enforcement figures from the 2008 Drug Harm Index, has been questioned.

There is also Vote: Social Development funding, through Child, Youth and Family and Work and Income New Zealand, for some treatment services for youth, families and individuals. These figures were not available at the time of printing. Further, government funding for drug and alcohol prevention activity has not been included.

We should therefore be cautious about conclusions around overall government spending on approaches to drug and alcohol problems. Certainly, there is a need for better and more easily available funding data across our various approaches. This would allow us to better determine what funding is going where and assess relative effectiveness at reducing harm.

 

Share:

Related See more

www.global drug survey logo print

Global Drug Survey 2020: What they're focusing on

NZ Drug Foundation is sharing details of the world's largest survey on drug use. This news item is published on behalf of the organisers of...

MoS nov 2019 thumbnail samuel

Sensational sex-and-drugs story sparks research interest

Back in 2016, a provocative Newshub headline introduced middle New Zealand to the existence of “drug-fuelled sex binges” known as chemsex. N...

MoS nov 2019 thumbnail on weed

No is a vote to maintain Aotearoa’s status quo

Some say cannabis law is a tool of race and class oppression. At the same time, many people with terminal illness or chronic pain have found...

MoS nov 2019 thumbnail tricia asha

Balancing justice's racist scales

With the 2020 cannabis referendum fast approaching, New Zealanders have a unique opportunity to let the government know what they want from ...

e substance newsletter promotional thumbnail

Subscribe to email updates

Get regular news, analysis and commentary on drugs issues in New Zealand. Free.

Sign up now!

DF WebAd DrugHelp 4

DrugHelp

Online support resource if you or someone you care about is struggling with drug use

Visit DrugHelp

Back to top